文献速递母胎医学产科

羊水置换治疗胎儿腹裂的随机对照试验

A randomised controlled trial of amnioexchange for fetal gastroschisis.
PubMed 文献 · BJOG · 2019-05-20

这项前瞻性、干预性随机研究在8个胎儿医学转诊中心比较了宫内羊水置换与假手术,两组均在孕30周注射类固醇并采用产后最小肠内喂养。64例患者随机分组,意向性分析显示主要复合指标(通气与肠外营养持续时间)及妊娠结局和并发症均无显著组间差异。作者认为该方案的羊水置换不是胎儿医疗的选择,但补充证明炎症参与腹裂致病,建议未来研究以减少炎症为目标。

要点

  • 羊水置换组与对照组在通气及肠外营养持续时间复合指标上无差异。
  • 意向性分析显示两组妊娠结局及并发症无显著差异。
  • 胆汁酸与铁蛋白及白介素1β(IL1β)之间发现明确相关性。

核心结论

  • 在人类中,按本方案进行的羊水置换不是胎儿医疗的选择;但补充证明炎症参与腹裂致病,建议未来研究以减少炎症为目标。

研究设计与样本

  • 前瞻性、干预性、随机研究,在8个胎儿医学转诊中心开展,共随机64例怀有腹裂胎儿的孕妇。
  • 两组均包含孕30周注射类固醇和产后最小肠内喂养的方案。

主要发现

  • 羊水置换组与对照组在基于通气及肠外营养持续时间的复合标准上无差异。
  • 意向性分析显示两组妊娠结局或并发症无显著组间差异。
  • 胆汁酸与铁蛋白及白介素1β(IL1β)之间发现明确相关性。

临床怎么用

  • 原文未据此给出推荐;作者结论为按本方案进行的羊水置换不是胎儿医疗的选择。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Morbidity in fetuses affected by gastroschisis is mainly the result of bowel ischaemic and inflammatory processes. Experimental studies on animal models show that clearing amniotic fluid from the digestive secretions by amnioexchange procedures reduces the inflammatory process. We evaluated the benefit of the amnioexchange procedure for fetal gastroschisis in humans. DESIGN: Prospective, interventional, randomised study. SETTING: Eight referral centres for fetal medicine. POPULATION: Pregnant women carrying a fetus with gastroschisis. METHODS: We compared, in utero, amnioexchange with a sham procedure. The protocol included, in both arms, steroid injections at 30 weeks of gestation and the use of postnatal minimal enteral feeding. MAIN OUTCOME MEASURES: The primary outcome was a composite variable based on the duration of ventilation and parenteral nutrition. Secondary outcomes were the effectiveness and safety of the amnioexchange procedure, including the rate of perinatal death, time to full enteral feeding, primary closure, and late feeding disorders. RESULTS: Sixty-four patients were randomised. There was no difference in the composite criteria between the amnioexchange and control groups. Based on an intention-to-treat analysis, there were no significant between-group differences in pregnancy outcome or complications. When studying the relationship between digestive compounds and amniotic fluid inflammatory markers, a clear correlation was found between bile acid and both ferritin and interleukin 1β (IL1β). CONCLUSIONS: In humans, amnioexchange, as described in our protocol, is not an option for fetal care; however, we provide supplementary proof of the involvement of inflammation in the pathogenicity of gastroschisis and suggest that future research should aim at reducing inflammation. ClinicalTrials.gov: NCT00127946. TWEETABLE ABSTRACT: A prospective, interventional, randomised study shows no benefit of amnioexchange for fetal gastroschisis in humans.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. Luton D, Mitanchez D, Winer N, et al. A randomised controlled trial of amnioexchange for fetal gastroschisis. BJOG. 2019. PMID: 31033140. doi:10.1111/1471-0528.15804

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。